Related Experiment Video

Updated: Jul 16, 2026

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
12:00

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Published on: July 5, 2017

Antioxidant activity of carvedilol in cardiovascular disease

Paresh Dandona1, Husam Ghanim, David P Brooks

  • 1Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, New York 14209, USA. pdandona@kaleidahealth.org

Journal of Hypertension
|March 14, 2007
PubMed

Insights

Carvedilol reduces oxidative and inflammatory stress, key factors in hypertension and atherosclerosis. Its antioxidant and anti-inflammatory properties may improve cardiovascular outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Oxidative and inflammatory stresses are central to hypertension and atherosclerosis development.
  • Oxidative stress promotes inflammation by activating pro-inflammatory pathways.
  • Understanding oxidative stress mechanisms is crucial for managing cardiovascular disease complications.

Purpose of the Study:

  • To explore the oxidative and anti-inflammatory effects of carvedilol.
  • To investigate carvedilol's potential in mitigating cardiovascular disease pathogenesis.

Main Methods:

  • Review of existing literature on carvedilol's effects on oxidative and inflammatory markers.
  • Analysis of studies investigating reactive oxygen species (ROS) scavenging and suppression by carvedilol.

Main Results:

  • Carvedilol demonstrates both reactive oxygen species (ROS)-scavenging and ROS-suppressive activities.
  • Carvedilol use is linked to a reduction in overall oxidative stress.
  • Emerging evidence indicates carvedilol possesses anti-inflammatory properties.

Conclusions:

  • Carvedilol's antioxidant and anti-inflammatory actions may contribute to its beneficial cardiovascular effects.
  • Further clinical research is warranted to confirm carvedilol's impact on clinical outcomes.
  • Carvedilol presents a potential therapeutic strategy for managing oxidative and inflammatory stress in cardiovascular diseases.

More Related Videos

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Related Concept Videos

Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...